Last reviewed · How we verify
Ketorolac 15mg
At a glance
| Generic name | Ketorolac 15mg |
|---|---|
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients (PHASE4)
- Comparison of Two Dosing Regimens of Intravenous Ketorolac for Post-Cesarean Pain Control (NA)
- Ketorolac Effects on Post-operative Pain and Lumbar Fusion (PHASE4)
- Safety of Short-course of NSAIDs in Pediatric Patients With CKD (PHASE4)
- Pain Management Study (PHASE4)
- ACU_Knee: Role of Acupuncture in Knee Prosthetic Surgery (NA)
- Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures (EARLY_PHASE1)
- Local Multimodal Injection Versus Regional Anesthesia in Controlling Pain for Treating Rotational Ankle Fractures (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketorolac 15mg CI brief — competitive landscape report
- Ketorolac 15mg updates RSS · CI watch RSS
- Cairo University portfolio CI